Novavax, Inc,  an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases  said  its vaccine is 100 percent effective at protecting against moderate to severe COVID-19 and 90.4 percent effective overall. Available data came from a phase 3 trial that enrolled 29,960 participants across 119 sites in the U.S. […]